Volume 21, Number 2—February 2015
CME ACTIVITY - Research
pH Level as a Marker for Predicting Death among Patients with Vibrio vulnificus Infection, South Korea, 2000–2011
Table 2
Variable | Reference values | Values for patients |
p value | |
---|---|---|---|---|
Nonsurvivors, n = 16 | Survivors, n = 18 | |||
Hematologic values | ||||
Leukocyte count/μL | 4,000–8,000 | 6,721 (1,030–25,950) | 9,687 (1,940–21,770) | 0.167 |
Hemoglobin, g/dL | 12.0–16.0 | 12.5 (7.3–17.8) | 11.5 (8.2–15.5) | 0.248 |
Platelets, 103/μL | 150–400 | 62 (13–147) | 81 (13–243) | 0.330 |
PT, s | 9.4–12.5 | 17.7 (10.5–30.4) | 14.9 (10.2–19.5) | 0.111 |
aPTT, s |
28.0–44.0 |
48.5 (28.8–103.0) |
37.4 (21.5–57.5) |
0.040 |
Arterial blood gas analysis values | ||||
pH | 7.350–7.450 | 7.08 (6.82–7.36) | 7.41 (7.22–7.50) | <0.001 |
HCO3, mmol/L | 21.0–28.0 | 8.4 (3.6–13.9) | 18.6 (8.7–25.6) | <0.001 |
PO2, mm Hg | 83.0–108.0 | 103.4 (69.2–157.0) | 86.6 (52.3–162.8) | 0.035 |
PCO2, mm Hg |
35.0–45.0 |
26.7 (14.3–41.0) |
28.8 (21.6–38.0) |
0.314 |
Clinical chemistry values | ||||
Albumin, g/dL | 3.50–5.20 | 2.63 (2.07–3.00) | 2.82 (1.66–3.84) | 0.201 |
BUN, mg/dL | 8.0–20.0 | 31.8 (10.0–56.9) | 22.6 (9.6–49.7) | 0.043 |
Creatinine, mg/dL | 0.5–1.3 | 3.59 (1.52–5.90) | 1.76 (0.60–3.90) | <0.001 |
Glucose, mg/dL | 60–109 | 134 (22–306) | 141 (40–300) | 0.764 |
Bilirubin, mg/dL |
0.2–1.2 |
7.5 (0.5–48.3) |
2.3 (0.5–4.1) |
0.094 |
Liver enzyme values | ||||
AST, IU/L | 5–40 | 443 (43–1,696) | 111 (30–323) | 0.006 |
ALT, IU/L |
5–40 |
100 (22–290) |
57 (17–133) |
0.020 |
APACHE II score | 18 (10–31) | 14 (10–32) | 0.036 |
*Data are expressed as median (range). ALT, alanine aminotransferase; APACHE, Acute Physiology and Chronic Health Evaluation; aPTT, activated partial thromboplastin time; AST, aspartate aminotransferase; BUN, blood urea nitrogen; HCO3, serum bicarbonate; PCO2, carbon dioxide partial pressure; PO2, partial pressure of oxygen; PT, prothrombin time.
Page created: January 16, 2015
Page updated: January 16, 2015
Page reviewed: January 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.